We are live on ! Find out more
Zurich Cantonal Bank

Zurich Cantonal Bank Portfolio holdings

AUM $46B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+10.62%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$43.5B
AUM Growth
+$2.64B
Cap. Flow
-$751M
Cap. Flow %
-1.72%
Top 10 Hldgs %
35.47%
Holding
2,607
New
56
Increased
1,180
Reduced
588
Closed
58

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$172M
2
TSLA icon
Tesla
TSLA
+$117M
3
ORCL icon
Oracle
ORCL
+$60.5M
4
CVS icon
CVS Health
CVS
+$60.1M
5
CRS icon
Carpenter Technology
CRS
+$40.4M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$263M
2
MSFT icon
Microsoft
MSFT
+$98.2M
3
NVDA icon
NVIDIA
NVDA
+$68.4M
4
MCD icon
McDonald's
MCD
+$66.2M
5
UNH icon
UnitedHealth
UNH
+$60.4M

Sector Composition

Rank Sector Weight
1 Technology 32.02%
2 Financials 17.25%
3 Consumer Discretionary 9.83%
4 Healthcare 9.66%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMNR icon
2451
Limoneira
LMNR
$250M
$7.19K ﹤0.01%
484
-109
-18% -$1.69K
MESO
2452
Mesoblast
MESO
$2.19B
$6.19K ﹤0.01%
384
-249
-39% -$3.64K
TVGN icon
2453
Tevogen Inc. Common Stock
TVGN
$27M
$6.1K ﹤0.01%
155
-65
-30% -$3.2K
TKNO icon
2454
Alpha Teknova
TKNO
$383M
$5.61K ﹤0.01%
906
-436
-32% -$2.05K
PRAX icon
2455
Praxis Precision Medicines
PRAX
$10.2B
$5.19K ﹤0.01%
98
-69
-41% -$3.35K
ALVO icon
2456
Alvotech
ALVO
$1.28B
$4.79K ﹤0.01%
585
-282
-33% -$2.4K
RNAC icon
2457
Cartesian Therapeutics
RNAC
$267M
$4.49K ﹤0.01%
439
-201
-31% -$2.26K
ALT icon
2458
Altimmune
ALT
$587M
$4.24K ﹤0.01%
1,125
-487
-30% -$1.88K
OMER icon
2459
Omeros
OMER
$978M
$4.1K ﹤0.01%
1,000
-358
-26% -$1.42K
CDXS icon
2460
Codexis
CDXS
$161M
$3.87K ﹤0.01%
1,587
-689
-30% -$1.88K
FCEL icon
2461
FuelCell Energy
FCEL
$1.64B
$3.7K ﹤0.01%
474
– –
MXCT icon
2462
MaxCyte
MXCT
$131M
$2.89K ﹤0.01%
1,830
-879
-32% -$1.53K
TECX
2463
Tectonic Therapeutic
TECX
$644M
$2.57K ﹤0.01%
164
-119
-42% -$2.46K
TRDA icon
2464
Entrada Therapeutics
TRDA
$273M
$2.51K ﹤0.01%
432
-314
-42% -$1.84K
BYND icon
2465
Beyond Meat
BYND
$232M
$1.93K ﹤0.01%
1,019
-23
-2% -$68
EDIT icon
2466
Editas Medicine
EDIT
$435M
$1.25K ﹤0.01%
360
– –
ARCT icon
2467
Arcturus Therapeutics
ARCT
$205M
$903 ﹤0.01%
49
– –
PLRX icon
2468
Pliant Therapeutics
PLRX
$65.6M
$897 ﹤0.01%
606
-265
-30% -$404
SCLX icon
2469
Scilex Holding
SCLX
$46.7M
$866 ﹤0.01%
44
– –
CMRC
2470
Commerce.com Inc Series 1
CMRC
$173M
$768 ﹤0.01%
154
– –
PRTA icon
2471
Prothena Corp
PRTA
$466M
$693 ﹤0.01%
71
-15,497
-100% -$119K
PLUR icon
2472
Pluri
PLUR
$19.6M
$651 ﹤0.01%
136
– –
TALK icon
2473
Talkspace
TALK
$867M
$530 ﹤0.01%
192
– –
DTIL icon
2474
Precision BioSciences
DTIL
$206M
$381 ﹤0.01%
69
– –
SGMO
2475
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$294 ﹤0.01%
436
– –
97 98
99
100 101

Similar funds

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Korea Investment Corp
Korea Investment Corp Seoul, South Korea $48.3B AUM 31.57% 1-Year Est. Return

Zurich Cantonal Bank's Q3 2025 Portfolio in Review

As of Q3 2025, Zurich Cantonal Bank held 2,607 positions worth $43.5B, up 6.4% from $40.9B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 4.4%. Zurich Cantonal Bank opened 56 new positions and exited 58, leaving the 2,607-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Zurich Cantonal Bank's largest Q3 2025 buy was Paramount Skydance Corp: 139,876 shares worth $2.65M.
  • Zurich Cantonal Bank added most to Bank of America in Q3 2025, an estimated $172M increase.
  • Zurich Cantonal Bank's biggest Q3 2025 reduction was UBS Group, cutting an estimated $263M.
  • Zurich Cantonal Bank fully exited Ansys in Q3 2025, selling an estimated $18.3M.
  • Zurich Cantonal Bank's ten largest holdings make up 35% of its $43.5B portfolio in Q3 2025.
  • Zurich Cantonal Bank opened 56 new positions and closed 58 in Q3 2025.
  • Zurich Cantonal Bank's portfolio value rose 6.4% quarter-over-quarter to $43.5B.

Based on Zurich Cantonal Bank's 13F filing for Q3 2025, filed 14 Nov 2025.